Author

Steven William Corso

Observed names: Corso, S.W., Corso, Steven, Corso, Steven W., S.W. Corso, Steven Corso, Steven W Corso, Steven W. Corso

Institution: University of South Carolina Upstate

Observed institutions: University of North Carolina at Chapel Hill, University of South Carolina Upstate, Mayo Clinic, Duke University, East Carolina University, Spartanburg Regional Medical Center, Missouri Valley Cancer Consortium, Sarah Cannon, Palmetto Hematology Oncology, Metro-Minnesota Community Oncology Research Consortium, Spartanburg Regional Healthcare System, Tennessee Oncology, National Cancer Institute

OpenAlex ID: A5109767638

Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma

2002 · John D. Hainsworth, Sharlene Litchy, et al. · Journal of Clinical Oncology · 416

Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study

2011 · William J. Irvin, Christine M. Walko, et al. · Journal of Clinical Oncology · 181

Phase III Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone: NCCTG N03C5

2006 · Charles L. Loprinzi, John W. Kugler, et al. · Journal of Clinical Oncology · 93

Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity

2016 · Daniel L. Hertz, Allison Deal, et al. · The Oncologist · 57

PDF

In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles

2015 · Daniel L. Hertz, Anna C. Snavely, et al. · British Journal of Clinical Pharmacology · 54

PDF

Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy

2022 · Elizabeth K Belcher, Eva Culakova, et al. · JNCI Journal of the National Cancer Institute · 31

Paclitaxel/Carboplatin/Etoposide Versus Paclitaxel/Topotecan for Extensive-Stage Small Cell Lung Cancer: A Minnie Pearl Cancer Research Network Randomized, Prospective Phase II Trial

2005 · F. Anthony Greco, Dana S. Thompson, et al. · The Oncologist · 13

Patients' Understanding of How Genotype Variation Affects Benefits of Tamoxifen Therapy for Breast Cancer

2014 · N.T. Brewer, J.T. DeFrank, et al. · Public Health Genomics · 8

PDF

In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles

2020 · Corso, Steven, Olajide, Oludamilola, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 5

PDF

Does increasing the daily tamoxifen dose in patients with diminished CYP2D6 activity increase toxicity?

2014 · Daniel Louis Hertz, Anna C. Snavely, et al. · Journal of Clinical Oncology · 4

Systemic inflammation and changes in physical well-being in patients with breast cancer: a longitudinal study in community oncology settings

2024 · Nikesha Gilmore, Yue Li, et al. · The Oncologist · 3

Association of changes of pro-inflammatory markers with physical function in women with breast cancer receiving chemotherapy.

2021 · Nikesha Gilmore, Elizabeth Belcher, et al. · Journal of Clinical Oncology · 2

Abstract SS2-10: Impact of COVID-19 on study sites: Survey analysis from the noninterventional POLARIS study

2021 · Debu Tripathy, Joanne L Blum, et al. · Cancer Research · 2

Abstract P1-03-02: CYP2D6 intermediate metabolizers includes patient groups with distinct metabolic activity

2015 · Daniel L Hertz, Anna C Snavely, et al. · Cancer Research · 1

Baseline telomere length and prediction of cognitive recovery after chemotherapy in patients with breast cancer: An NCORP prospective cohort study.

2026 · Jonas M. Ndeke, Kevin Spath, et al. · Journal of Clinical Oncology

Abstract P3-01-05: Laboratory monitoring in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2–) advanced breast cancer treated with palbociclib in a real-world setting: Results from POLARIS

2023 · Gabrielle B. Rocque, Joanne L. Blum, et al. · Cancer Research

Patients' Understanding of How Genotype Variation Affects Benefits of Tamoxifen Therapy for Breast Cancer

2020 · DeFrank, J.T., Corso, S.W., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)

PDF

Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study

2020 · Weck, Karen E., Anderson, Steven M., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)

PDF

Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity

2020 · Hertz, Daniel L., Olajide, Oludamilola, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)

PDF

Prechemotherapy cognitive function in 362 breast cancer (BC) patients and 362 age-paired controls without cancer: A nationwide longitudinal trial conducted through the University of Rochester Cancer Center (URCC) Community Clinical Oncology Program (CCOP) Research Base (RB).

2014 · Michelle Christine Janelsins, Charles E. Heckler, et al. · Journal of Clinical Oncology

Front & Back Matter

2014 · N.T. Brewer, J.T. DeFrank, et al. · Public Health Genomics

Rituximab a s F irst-Line a nd M aintenance T herapy f or Patients W ith I ndolent N on-Hodgkin's L ymphoma

2002 · John D. Hainsworth, Sharlene Litchy, et al.

Works count: 22

Citation count: 870

H-index: 8

I10-index: 7